Literature DB >> 12586838

Identification of phospholipid scramblase 1 as a novel interacting molecule with beta -secretase (beta -site amyloid precursor protein (APP) cleaving enzyme (BACE)).

Satoshi Kametaka1, Masahiro Shibata, Kimiho Moroe, Shiro Kanamori, Yoshiyuki Ohsawa, Satoshi Waguri, Peter J Sims, Kazuo Emoto, Masato Umeda, Yasuo Uchiyama.   

Abstract

beta-Site amyloid precursor protein (APP)-cleaving enzyme (BACE) is an integral membrane aspartic proteinase responsible for beta-site processing of APP, and its cytoplasmic region composed of 24 amino acid residues has been shown to be involved in the endosomal localization of BACE. With the yeast two-hybrid screening, we found that the cytoplasmic domain of phospholipid scramblase 1 (PLSCR1), a type II integral membrane protein, interacts with the cytoplasmic region of BACE. In cultured cells, BACE and PLSCR1 were colocalized in the Golgi area and in endosomal compartments, whereas they were co-redistributed in late endosome-derived multivesicular bodies when treated with U18666A, suggesting that both proteins share a common trafficking pathway in cells. Co-immunoprecipitation analysis showed that both proteins form a protein complex at an endogenous expression level in the human neuroblastoma SH-SY5Ycells, and the dileucine residue of the BACE tail is also revealed to be essential for the physical interaction with PLSCR1 in vitro and in vivo. Moreover, both BACE and PLSCR1 were localized in a low buoyant lipid microdomain in SH-SY5Y cells. The dileucine-defective BACE mutant was also fractionated into the lipid microdomain, but much less stably than wild-type BACE. Taken together, our current study suggests the functional involvement of PLSCR1 in the intracellular distribution of BACE and/or recruitment of BACE into the detergent-insoluble lipid raft.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586838     DOI: 10.1074/jbc.M208611200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

Review 2.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

Review 3.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

4.  Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.

Authors:  Anne M Cataldo; Paul M Mathews; Anne Boyer Boiteau; Linda C Hassinger; Corrinne M Peterhoff; Ying Jiang; Kerry Mullaney; Rachael L Neve; Jean Gruenberg; Ralph A Nixon
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

Review 5.  Beta-secretase: structure, function, and evolution.

Authors:  Chitra Venugopal; Christina M Demos; K S Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

Review 6.  A new cross-linking strategy: protein interaction reporter (PIR) technology for protein-protein interaction studies.

Authors:  Xiaoting Tang; James E Bruce
Journal:  Mol Biosyst       Date:  2010-03-16

7.  Identification of PLSCR1 as a protein that interacts with RELT family members.

Authors:  John K Cusick; Andrea Mustian; Aaron T Jacobs; Mary E Reyland
Journal:  Mol Cell Biochem       Date:  2011-11-04       Impact factor: 3.396

8.  Spatial segregation of gamma-secretase and substrates in distinct membrane domains.

Authors:  Kulandaivelu S Vetrivel; Haipeng Cheng; Seong-Hun Kim; Ying Chen; Natalie Y Barnes; Angèle T Parent; Sangram S Sisodia; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

Review 9.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

Review 10.  Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Authors:  Richard J Cenedella
Journal:  Lipids       Date:  2009-05-14       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.